Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Computational Pathologic Analysis
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Prostate biopsy is the definitive examination to establish the diagnosis of prostate cancer, but up to 40% of these biopsies overestimate or underestimate the severity of the disease. A novel biopsy needle system captures substantially more tissue than standard of care needles, but it is important to assess the retrieval of tissue for pathologic analyses. This study will compare quality and quantity of tissue retrieved by both systems. Further, tissue will be analyzed using computational pathology algorithms for atypical small acinar proliferation and Gleason scores in terms of tissue area, tissue length, and tissue tortuosity.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Mężczyzna dorosły
- •Podwyższony wskaźnik PSA (≥0,15)
- •Zmiana widoczna w badaniu MRI
- •Wynik PIRADS co najmniej 3
- •Chęć i możliwość udziału w badaniu
✗ Disqualifies
- •Wcześniejsze leczenie raka prostaty (operacja, radioterapia lub chemioterapia)
- •Zaburzenia pamięci lub poznawcze
- •Poprzednie więzienie lub obecna inkarceracja
- •Nieznajomość języka angielskiego
- •Zaawansowany rak prostaty z przerzutami
- •Innych nowotworów złośliwych jednocześnie
- •Infekcja HIV, HBV lub HCV
- •Zły stan ogólny
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 4, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (3)
NYU Langone
New York, United States
Duke University
Durham, United States
Novant Health Coastal Carolina Medical Center
Hardeeville, United States
Trial contact
Thomas Lawson, PhD
Ted Belleza, BA
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/5/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.